Phase 4 Pharmacovigilance Trial of Paromomycin Injection for the Treatment of Visceral Leishmaniasis in India

Background. A phase 3 study demonstrated the safety and efficacy of paromomycin (paromomycin IM injection) for treatment of VL in an inpatient setting. Methods. This phase 4 study was conducted to assess the safety and efficacy of paromomycin in children and adults in an outpatient setting in Bihar,...

Descripción completa

Detalles Bibliográficos
Autores principales: Sinha, Prabhat K., Jha, T. K., Thakur, Chandreshwar P., Nath, Devendra, Mukherjee, Supriyo, Aditya, Amrendra Kumar, Sundar, Shyam
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2011
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235903/
https://www.ncbi.nlm.nih.gov/pubmed/22174722
http://dx.doi.org/10.1155/2011/645203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3235903/
https://www.ncbi.nlm.nih.gov/pubmed/22174722
http://dx.doi.org/10.1155/2011/645203

Ejemplares similares